SLC6A1 and psychiatric disorder: Mutations of SLC6A1 were reported in a variety of neurological and psychiatric disorders, myoclonic atonic epilepsy, intellectual disability (Johannesen et al., 2018, 1), autism (Wang et al., 2020), as well as schizophrenia (Rees et al., 2020).